Incyte (INCY) stock

Last close 120.30 USD (Nov 10, 2026), on the day −1.3 %.

• Sector: Healthcare, Biotechnology.
• Market cap: 24.8B USD.
• P/E: 60.9. Forward P/E: 14.1.
• Over 52 weeks: low 90.30 USD, high 129.93 USD, price change +13.5 %.
• Analysts' average 12-month target from Yahoo Finance: 132 USD (24 analysts). Not our estimate.

Earnings

• Feb 9, 2027: EPS not yet, estimate 1.97
• Oct 29, 2026: EPS −3.60, estimate −3.87
• Jul 28, 2026: EPS 3.09, estimate 2.15
• Apr 28, 2026: EPS 1.81, estimate 1.34
• Feb 10, 2026: EPS 1.80, estimate 1.92
• Oct 28, 2025: EPS 2.26, estimate 1.64

Which large investors hold it

• Dodge & Cox – 0.7 % of the portfolio
• Ray Dalio – 0.1 % of the portfolio

In baskets

• Biotech

Similar companies: ARGX · BMRN · BNTX · EXEL · MRNA · REGN · VRTX